Allurion, maker of a swallowable gastric balloon designed to facilitate weight loss, has partnered with Medtronic in a pilot agreement to distribute the device in
A novel treatment for healing diabetic foot ulcers (DFUs) could be on the horizon for people with diabetes in the US. Diabetic foot ulcers are
From April 2023 Medicare has increased access to continuous glucose monitoring (CGM) in the US to people on insulin therapies who are also having hypoglycemia.
While continuous glucose monitors (CGMs) can provide real-time data and alerts to help people with diabetes make informed decisions about their health, it has been
A campaign has been launched urging everyone with diabetes to carry a card featuring potentially life-saving advice. The HypoCard, which can fit inside a wallet
A study supported by JDRF has found that hybrid closed-loop technology improves maternal glucose levels during pregnancy complicated by Type 1 diabetes, compared to traditional
It is estimated that around 35% of patients with Type 1 and Type 2 diabetes have elevated distress levels, but a digital health application (DiGA)
Glooko has launched a sleek new Glooko Mobile App in order to make it easier for users with diabetes to navigate, to organize their data
The U.S. Food and Drug Administration (FDA) has now approved Lantidra, the first allogeneic (donor) pancreatic islet cellular therapy made from deceased donor pancreatic cells for
Bigfoot’s diabetes management system is designed to address problems such as missed doses, inadequate insulin intensification and dosing errors that affect people with diabetes who
